Understanding ESR1 Mutations in Breast Cancer
Breast cancer’s complex nature often includes the challenge of hormone resistance, primarily driven by ESR1 mutations in estrogen receptor-positive cases. These mutations thwart conventional hormone therapies, prompting the need for advanced detection through genomic testing and innovative treatments like selective estrogen receptor degraders. Explore the mechanisms, detection methods, and evolving treatment strategies addressing these mutations. […]
3 minute read